{"filing":{"accession_number":"0001077183-26-000029","cik":"0001077183","ticker":"NEO","company_name":"NEOGENOMICS INC","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"neo-20260615.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718326000029/neo-20260615.htm"},"events":[{"id":11154,"run_id":9777,"accession_number":"0001077183-26-000029","anchor_item_number":"8.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"NeoGenomics announced the commencement of a proposed offering of convertible senior notes due 2032 to qualified institutional buyers under Rule 144A. Convertible notes are inherently dilutive securities that can be converted into equity, making this a material capital-raising event that would affect investor assessment of share dilution and the company's financing strategy.","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":[{"id":7673,"accession_number":"0001077183-26-000029","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"NeoGenomics announced the commencement of a proposed offering of convertible senior notes due 2032 to qualified institutional buyers under Rule 144A. Convertible notes are inherently dilutive securities that can be converted into equity, making this a material capital-raising event that would affect investor assessment of share dilution and the company's financing strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T21:26:05.928619+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7673,"accession_number":"0001077183-26-000029","item_number":"8.01","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"NeoGenomics announced the commencement of a proposed offering of convertible senior notes due 2032 to qualified institutional buyers under Rule 144A. Convertible notes are inherently dilutive securities that can be converted into equity, making this a material capital-raising event that would affect investor assessment of share dilution and the company's financing strategy.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T21:26:05.928619+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-06-15"}]}